U.S. Laboratory Informatics Market Size To Hit USD 1.87 BN By 2034
The U.S. laboratory informatics market size was exhibited at USD 1.32 billion in 2024 and is projected to hit around USD 1.87 billion by 2034, growing at a CAGR of 3.6% during the forecast period 2025 to 2034.
| Report Coverage | Details |
| Market Size in 2025 | USD 1.36 Billion |
| Market Size by 2034 | USD 1.87 Billion |
| Growth Rate From 2025 to 2034 | CAGR of 3.6% |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Segments Covered | Product, Delivery Mode, Component, End-use |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Key Companies Profiled | Thermo Fisher Scientific, Inc.; Waters; LabWare; Core Informatics; LabVantage Solutions, Inc.; LabLynx, Inc.; PerkinElmer Inc.; Abbott; Agilent Technologies, Inc.; IDBS |
The growing demand for laboratory automation is expected to boost the adoption of laboratory information systems in the future. Surging demand for scientific data integration solutions among end-use industries including life sciences, Contract Research Organizations (CROs), food & beverage, and chemicals is projected to boost the market growth. The increasing need for clinical workflow management in laboratories to improve operational efficiency is likely to propel the market in the coming years.
Furthermore, the rising adoption of Laboratory Information Management Systems (LIMS) among independent and hospital-based labs to reduce the incidence of diagnostic errors and manage high data volumes is one of the key factors stirring up the adoption of laboratory informatics
in the U.S. The COVID-19 pandemic affected the market as it has enforced the government and agencies to develop and introduce the COVID-19 vaccine to control the severity in cases. In addition, high volumes of WHO-recommended COVID-19 tests encouraged the implementation of healthcare laboratory informatics solutions. Likewise, numerous healthcare laboratory informatics market players are quickly incorporating Artificial Intelligence (AI) and data analytics to conduct further research on the different virus strains.
Significant adoption of LIMS has been seen since the COVID-19 pandemic onset, allowing healthcare professionals to focus on drug and vaccine development by smoothening data collection procedures. Key players in the laboratory information systems are collaborating with public and private sector groups to employ advanced technologies for executing COVID-19-testing capabilities. In addition, laboratory information systems offer benefits, such as improved regulatory compliance, systems process optimization, intellectual property rights protection, paperless information management, and reduced throughput time.
They also offer improved information quality, reduce the labor cost, and provide faster & effective data analytics. Owing to the associated benefits, these systems are being increasingly used by CROs, biobanks, and academic research institutes. Furthermore, the growing adoption of wireless technologies in laboratories to allow remote access to information is estimated to fuel growth prospects. In addition, advancements in laboratory equipment help in replacing manual data evaluation methods, including the construction of calibration curves, and measuring peak areas or height in a shorter time than traditional methods. For instance, the Autosampler robotic system helps in sample preparation, which eliminates errors and saves cost & time on process execution.
On the basis of products, the market has been further divided into LIMS, Electronic Lab Notebooks (ELN), Scientific Data Management Systems (SDMS), Laboratory Execution Systems (LES), Electronic Data Capture (EDC) & Clinical Data Management Systems (CDMS), Chromatography Data Systems (CDS), and Enterprise Content Management (ECM). The LIMS segment accounted for the largest revenue share of more than 45.0% in 2024 and is expected to witness lucrative growth over the forecast period. The growth of the segment can be attributed to the growing demand for integrated LIMS platforms in accordance with the requirements of life sciences and research companies to reduce the incidence of errors in data management and improve analysis.
The segment will continue to lead the market even during the forecast years. Electronic Lab Notebooks (ELN) accounted for the second-largest share of the global market and is poised to exhibit steady growth due to increasing adoption by research organizations to process unstructured information, enable easy knowledge sharing, and ensure intellectual property protection. The rising penetration of mobile devices is further boosting the popularity of ELNs. Enterprise Content Management (ECM) is anticipated to exhibit noteworthy growth over the forecast period. This can be attributed to advantages offered by ECM, such as cost reduction, process automation, reduction of resource bottlenecks, effective content sharing, minimization of the number of lost documents, and better risk management.
On the basis of modes of delivery, the market has been further categorized into on-premise, web-hosted, and cloud-based. The cloud-based solutions segment accounted for the largest revenue share of more than 40.00% in 2024 and is projected to grow at fastest rate over the forecast period. It provides remote access to data and reduces efforts associated with the retrieval of information. As the data is stored remotely on the cloud, hardware failures do not result in data loss because of networked backups. Companies using cloud-based solutions do not require external servers and equipment, thereby reducing the cost.
Remote access to data and real-time data tracking are some of the other associated advantages that are expected to contribute to the growth of the segment. On-premise solutions offer users complete control over data, hardware, and software platforms. However, the market for on-premise delivery mode is projected to expand at a relatively slower rate owing to disadvantages, such as the long duration of the implementation process and high set-up cost associated with various hardware. Increasing adoption of cloud computing solutions is likely to further slow down the growth of web-based & on-premise solutions over the forecast period.
On the basis of components, the market has been further segmented into services and software. The services segment dominated the market in 2024 and is projected to grow at fastest rate over the forecast period. It will be the most promising segment throughout the forecast period. Increased outsourcing of laboratory information management solutions is supplementing the growth of the segment. These services are outsourced by large pharmaceutical research labs due to the lack of resources and skill set required for the deployment of analytics.
The software segment is estimated to register healthy growth during the same period owing to the availability of technologically advanced software, such as SaaS, which offers effective information management solutions for laboratories. These software are capable of performing critical functions, such as data capture, transfer, interpretation, analysis, and storage. Upgraded versions of these software are required to effectively perform the aforementioned functions. Owing to the improved efforts of clinicians and researchers for the advancement of lab operations and the growing number of samples in the labs, the demand for software is growing, which is contributing to the segment growth.
On the basis of end-use, the market has been further divided into life sciences, Contract Research Organizations (CROs), chemical industry, petrochemical refineries and oil & gas, food & beverages and agriculture, environmental testing labs, and others. The life sciences end-use segment accounted for the largest share of more than 28.0% in 2024. The CROs segment is expected to dominate the market, in terms of growth rate. The segment is estimated to register the fastest CAGR of 4.1% from 2023 to 2030. This growth can be attributed to the growing trend of outsourcing by life science companies. The rising number of clinical trials, growing need to reduce operational cost, and surging demand for novel drugs & devices are expected to create a shift from in-house manufacturing to outsourcing.
The growing adoption of LIMS by CROs to reduce total operational cost is likely to aid market growth. The life sciences companies segment is anticipated to account for the second-largest revenue share by 2030. This can be attributed to the growing demand for laboratory informatics to improve product quality, develop innovative products, and enhance operational efficiency. Increasing advancements in the healthcare industry due to rising R&D activities in the field of medicinal research are poised to fuel the demand for laboratory information systems in the coming years.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the U.S. laboratory informatics market
By Product
By Delivery Mode
By Component
By End-use
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers